At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 32 enrolled
Drug / intervention
external slt +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pioneer Study: External Selective Laser Trabeculoplasty for Treating Uncontrolled Open Angle Glaucoma
In Brief
A Phase 1 clinical trial evaluating external slt and standard slt for Primary Open Angle Glaucoma. Completed, enrolled 32 participants across 3 sites.
Detailed Summary
The purpose of this study is to evaluate the advantages and disadvantages of external selective laser trabeculoplasty (SLT) in treating open angle glaucoma,compared to traditional SLT.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Open Angle Glaucoma
CountriesIsrael
Collaborators--
Timeline
Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJun 2011
Enrollment StartSep 2011
Primary CompletionJan 2012
TodayJul 2026
First PostedJun 28, 2011
Enrollment StartSep 1, 2011
Primary CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.0 years ago
Interventions
external sltdevice
Nd:YAG LASER SLT perilimbal above trabecular meshwork 180 degrees ,100 lasering dots
standard sltdevice
Nd:YAG LASER SLT gonioscopic laser treatment